ABC
NVCR icon

Associated Banc-Corp’s NovoCure NVCR Stock Holding History

Associated Banc-Corp’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36
Closed -$6K – 674
2020
Q4 		$6K Hold
36
– – ﹤0.01% 474
2020
Q3 		$4K Hold
36
– – ﹤0.01% 486
2020
Q2 		$2K Buy
36
+6
+20% +$395 ﹤0.01% 711
2020
Q1 		$2K Buy
+30
New +$2.37K ﹤0.01% 634

Other funds holding NVCR

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Associated Banc-Corp's NVCR Position: Q1 2021 in Review

Associated Banc-Corp sold out of NovoCure (NVCR) in Q1 2021, closing a stake of 36 shares — an estimated $6K sold.

Associated Banc-Corp first reported a position in NVCR in Q1 2020 and held it in 4 quarters. The position peaked at $6K in Q4 2020. 327 funds tracked by Wall St. Rank hold NVCR as of Q1 2021.

  • Associated Banc-Corp reported no remaining NovoCure position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 36 NovoCure shares in Q1 2021, an estimated $6K.
  • Associated Banc-Corp first reported a position in NovoCure in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's NovoCure position peaked at $6K in Q4 2020.
  • 327 funds tracked by Wall St. Rank held NovoCure as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.